Table 2.
HRs with 95% CIs for the association between change in cardiorespiratory fitness and prostate cancer incidence and mortality
Incidence | Model 1 | Model 2 | Model 3 | Model 4 | N | Cases | ||||
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |||
% change in VO2max (L/min) | 0.97*** | 0.96 to 0.98 | 0.98** | 0.97 to 0.99 | 0.98** | 0.97 to 0.99 | 0.98** | 0.96 to 0.99 | 57 652 | 592 |
Change in VO2max (L/min) | 0.29*** | 0.24 to 0.51 | 0.45** | 0.26 to 0.77 | 0.44** | 0.25 to 0.77 | 0.46** | 0.27 to 0.80 | 57 652 | 592 |
Mortality | ||||||||||
% change in VO2max (L/min) | 0.98 | 0.94 to 1.03 | 0.99 | 0.95 to 1.02 | 0.99 | 0.95 to 1.02 | 0.98 | 0.94 to 1.02 | 57 652 | 46 |
Change in VO2max (L/min) | 0.48 | 0.08 to 2.86 | 0.55 | 0.12 to 2.53 | 0.52 | 0.11 to 2.37 | 0.38 | 0.07 to 2.11 | 57 652 | 46 |
Model 1: adjusted for baseline fitness. Model 2: adjusted for baseline fitness, age, education and year of last test. Model 3: adjusted for baseline fitness, age, education, year of last test and body mass index. Model 4: adjusted for baseline fitness, age, education, year of last test, body mass index and smoking.
*p<0.05, **p<0.01, ***p<0.001.
VO2max, estimated maximal oxygen consumption.